Picture of Taiyen Biotech Co logo

1737 Taiyen Biotech Co Cashflow Statement

0.000.00%
tw flag iconLast trade - 00:00
Consumer DefensivesConservativeSmall CapNeutral

Annual cashflow statement for Taiyen Biotech Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line429464510531329
Depreciation
Amortisation
Non-Cash Items-26.7-12.40.594-6.247
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-242-298-100-139-120
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities331339600581455
Capital Expenditures-283-265-389-246-342
Purchase of Fixed Assets
Other Investing Cash Flow Items14912.337.416.52.35
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-133-252-351-230-339
Financing Cash Flow Items-4.831463.989.9720.6
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities-278-181-28.4-548-199
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-80.7-93.5220-197-84.4